Keyphrases
Treatment Response
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Cervical Carcinoma
100%
Positron Emission Tomography
85%
Early Clearance
71%
Complete Response
57%
Messenger RNA (mRNA)
57%
Confidence Interval
28%
Hazard Ratio
28%
Multivariable
28%
Overall Survival
28%
Cervical Cancer
28%
Chemoradiation
28%
Improved Survival
28%
Patient Outcomes
14%
Kaplan-Meier Method
14%
Follow-up Time
14%
Risk Stratification
14%
Prognostic Significance
14%
Outcome Prediction
14%
Prognostic Information
14%
RNA-based
14%
Pelvic Control
14%
Subset Analysis
14%
RNA Detection
14%
High-risk Human Papillomavirus Infection
14%
Genital Swabs
14%
Risk Decision
14%
Treatment Escalation
14%
Medicine and Dentistry
Treatment Response
100%
Uterine Cervix Carcinoma
100%
Wart Virus
100%
Positron Emission Tomography
85%
Messenger RNA
57%
Hazard Ratio
28%
Overall Survival
28%
Cervical Cancer
28%
Chemoradiotherapy
28%
Pelvis
14%
Kaplan Meier Method
14%
Risk Stratification
14%
Papillomavirus Infection
14%
Nursing and Health Professions
Treatment Response
100%
Positron Emission Tomography
100%
Uterine Cervix Carcinoma
100%
Messenger RNA
66%
Confidence Interval
33%
Overall Survival
33%
Hazard Ratio
33%
Uterine Cervix Cancer
33%
Chemoradiotherapy
33%
Treatment Outcome
16%
Kaplan Meier Method
16%
Papillomavirus Infection
16%
Pharmacology, Toxicology and Pharmaceutical Science
Uterine Cervix Carcinoma
100%
Human Papillomavirus
100%
Messenger RNA
57%
Overall Survival
28%
Chemoradiation Therapy
28%
Uterine Cervix Cancer
28%
Papillomavirus Infection
14%
Immunology and Microbiology
Wart Virus
100%
Positron Emission Tomography
75%
Overall Survival
25%
Pelvis
12%